We turn lab-scale breakthroughs into robust, regulated, and profitable operations — so your science reaches the market with the economics, data, and compliance it needs to win.
At MAS Industrial Biotech we specialize in converting early-stage scientific advances into validated, regulated, and economically sustainable industrial processes. We sit between the lab and the plant — translating biology and chemistry into engineering decisions that protect your runway, your margins, and your timeline.
Whether you are moving from 10 L to 10,000 L, preparing your first regulatory dossier, or building the commercial story that unlocks your next round, we engage where it moves the needle.
We bridge the critical gap from bench to industrial fermentor — designing, modeling, and de-risking scale-up trajectories while optimizing unit economics.
We plan and execute pilot campaigns, field trials, and validation runs — producing the data packages that regulators, investors, and customers actually require.
We help startups and leadership teams translate scientific capability into commercial strategy — identifying high-value applications, securing partnerships, and unlocking revenue.
From bench to pilot to plant, our engagements touch the same real systems your team works with every day — scale-up bioreactors, field trials, and downstream processing.
Fermentation and cell-culture scale-up from bench to industrial volumes — including impeller design, aeration, mass transfer, and heat management at production scale.
Planning, executing, and analyzing field trials and pilot campaigns that generate the validated data regulators, investors, and customers actually trust.
Separation, purification, and formulation — from primary recovery through final product spec. We optimize for yield, quality, and unit economics.
Our approach is built for startups and companies that need decisions, not decks. Four stages, clear deliverables, and hands-on involvement where it matters most.
We understand your science, targets, and constraints — then align on what success looks like technically and commercially.
We identify the specific bioprocess, regulatory, or commercial gaps that actually block scale — and size their impact.
We deliver a de-risked scale-up, regulatory, or commercial plan with defined milestones, CAPEX/OPEX and decision gates.
We stay hands-on through trials, dossiers, and partnerships — until the process is running and the milestones are hit.
Biotech scale-up fails in the details. We live in those details, and we're built to work alongside your team — not in parallel to it.
We've scaled real processes in fermentation, oils, and biomass — not just written reports about them.
Technical, regulatory, and commercial under one roof — so your scale-up, dossier, and go-to-market are coherent, not fragmented.
Pragmatic, fast, and obsessed with unit economics. We protect your runway and your timeline.
From alternative proteins and nutritional oils to biofuels and biomaterials — we bring patterns from adjacent industries that save years.
MAS Industrial Biotech is led by someone who has actually scaled biomolecule production — through field trials, plants, regulators, and commercial launch.
Results-driven executive with 15+ years leading industrial biotechnology projects across product innovation, regulatory strategy, IP development, and large-scale implementation.
Built and scaled biomolecule production facilities — from early-stage field trials to full industrial processing — with demonstrated results on the ground, not on slideware.
Hands-on experience securing USDA and FDA approvals, protecting IP, and navigating the approval pathways that determine whether a process reaches the market.
Leads high-impact ventures across LatAm and the U.S. — combining operational excellence with cross-functional leadership and stakeholder engagement.
Tell us where your process is today. In a 30-minute introductory call, we'll surface the 2–3 bottlenecks that matter most and outline a path forward.
Email us →